Occurrence and fate of the angiotensin II receptor antagonist transformation product valsartan acid in the water cycle - A comparative study with selected β-blockers and the persistent anthropogenic wastewater indicators carbamazepine and acesulfame

Water Research

Volumn 47, Issue 17, 2013, Pages 6650-6659

  Nödler, Karsten ^a   Hillebrand, Olav ^a   Idzik, Krzysztof ^a   Strathmann, Martin ^b   Schiperski, Ferry ^c   Zirlewagen, Johannes ^c   Licha, Tobias ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b IWW WATER CENTRE   (Germany)

^c TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Acesulfame; Beta blockers; Carbamazepine; Surface water; Valsartan acid; Water treatment

Indexed keywords

ACTIVATED CARBON; ACTIVATED CARBON TREATMENT; ACTIVATED SLUDGE PROCESS; AMIDES; EFFLUENTS; GROUNDWATER; OZONE WATER TREATMENT; OZONIZATION; POTABLE WATER; WASTEWATER TREATMENT; WATER DISTRIBUTION SYSTEMS; WATER FILTRATION;

ACESULFAME; ANGIOTENSIN II; ATENOLOL; BETA-BLOCKERS; CARBAMAZEPINE; COMPARATIVES STUDIES; RECEPTOR ANTAGONISTS; TRANSFORMATION PRODUCTS; VALSARTAN; VALSARTAN ACID;

SURFACE WATERS;

ACESULFAME; ACTIVATED CARBON; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANDESARTAN; CARBAMAZEPINE; DRINKING WATER; GROUND WATER; IRBESARTAN; LOSARTAN; METOPROLOL; SOTALOL; SURFACE WATER; TAP WATER; VALSARTAN;

ACTIVATED CARBON; ACTIVATED SLUDGE; CARBOXYLIC ACID; COMPARATIVE STUDY; DRINKING WATER; DRUG; FILTRATION; SEWAGE; SURFACE WATER; WATER TREATMENT;

ACTIVATED SLUDGE; ARTICLE; COMPARATIVE STUDY; FILTRATION; PRIORITY JOURNAL; SEWAGE; SOLID PHASE EXTRACTION; WASTE WATER; WASTE WATER TREATMENT PLANT; WATER CYCLE;

ACESULFAME; BETA-BLOCKERS; CARBAMAZEPINE; SURFACE WATER; VALSARTAN ACID; WATER TREATMENT;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN RECEPTOR ANTAGONISTS; CARBAMAZEPINE; DRINKING WATER; GEOGRAPHY; GERMANY; GROUNDWATER; HUMAN ACTIVITIES; HUMANS; SURFACE PROPERTIES; TETRAZOLES; THIAZINES; VALINE; WASTE WATER; WATER CYCLE; WATER POLLUTANTS, CHEMICAL;

EID: 84886087860     PISSN: 00431354     EISSN: 18792448     Source Type: Journal    
DOI: 10.1016/j.watres.2013.08.034     Document Type: Article

References (48)

1. Anlauf M. Antihypertonika. Arzneiverordnungs-Report 2012 2012, 225-262. Springer Medizin Verlag Berlin, Heidelberg. U. Schwabe, D. Paffrath (Eds.).
2. Barbieri M., Licha T., Nödler K., Carrera J., Ayora C., Sanchez-Vila X. Fate of β-blockers in aquifer material under nitrate reducing conditions: batch experiments. Chemosphere 2012, 89(11):1272-1277.
3. Batt A.L., Kostich M.S., Lazorchak J.M. Analysis of ecologically relevant pharmaceuticals in wastewater and surface water using selective solid-phase extraction and UPLC-MS/MS. Anal. Chem. 2008, 80(13):5021-5030.
4. Berkner S., Thierbach C. Biodegradability and transformation of human pharmaceutical active ingredients in environmentally relevant test systems. Environ. Sci. Pollut. Res. Int. 2013, (in press). 10.1007/s11356-013-1868-6.
5. Bhardwaj G. How the antihypertensive losartan was discovered. Expert Opin. Drug Discov. 2006, 1(6):609-618.
6. BMG Gesetzliche Krankenversicherung, Mitglieder, mitversicherte Angehörige und Krankenstand - Monatswerte Januar bis Februar 2012. Report in German about the coverage of the statutorily health insurance in January/February 2012 2012, Published by the, German Fedaral Ministry of Health.
7. Bruce G.M., Pleus R.C., Snyder S.A. Toxicological relevance of pharmaceuticals in drinking water. Environ. Sci. Technol. 2010, 44(14):5619-5626.
8. Buerge I.J., Buser H.-R., Kahle M., Müller M.D., Poiger T. Ubiquitous occurrence of the artificial sweetener acesulfame in the aquatic environment: an ideal chemical marker of domestic wastewater in groundwater. Environ. Sci. Technol. 2009, 43(12):4381-4385.
9. Bundermann G. 30 years of RWW's practical experience with an advanced microbiological water treatment system of Ruhr river water - "The Muelheim treatment process 1976-2006". Recent Progress in Slow Sand Filtration and Alternative Biofiltration Processes 2006, 30-38. IWA Publishing, London, UK. R. Gimbel, N.J.D. Graham, M.R. Collins (Eds.).
10. Clara M., Strenn B., Kreuzinger N. Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations on the behaviour of carbamazepine in wastewater treatment and during groundwater infiltration. Water. Res. 2004, 38(4):947-954.
11. Coiffard C.A.C., Coiffard L.J.M., De Roeck-Holtzhauer Y.M.R. Photodegradation kinetics of acesulfame-K solutions under UV light: effect of pH. Zeitschrift für Lebensmitteluntersuchung und - Forschung A 1999, 208(1):6-9.
12. Gabet-Giraud V., Miège C., Choubert J.M., Ruel S.M., Coquery M. Occurrence and removal of estrogens and beta blockers by various processes in wastewater treatment plants. Sci. Total. Environ. 2010, 408(19):4257-4269.
13. Godbillon J., Duval M. Determination of two metoprolol metabolites in human urine by high-performance liquid chromatography. J. Chromatogr. B. Biomed. Sci. Appl. 1984, 309(1):198-202.
14. Gracia-Lor E., Martínez M., Sancho J.V., Peñuela G., Hernández F. Multi-class determination of personal care products and pharmaceuticals in environmental and wastewater samples by ultra-high performance liquid-chromatography-tandem mass spectrometry. Talanta 2012, 99:1011-1023.
15. Heberer T. Tracking persistent pharmaceutical residues from municipal sewage to drinking water. J. Hydrol. 2002, 266(3-4):175-189.
16. Helbling D.E., Hollender J., Kohler H.-P.E., Singer H., Fenner K. High-throughput identification of microbial transformation products of organic micropollutants. Environ. Sci. Technol. 2010, 44(17):6621-6627.
17. Hillebrand O., Nödler K., Licha T., Sauter M., Geyer T. Caffeine as an indicator for the quantification of untreated wastewater in karst systems. Water. Res. 2012, 46(2):395-402.
18. Hillebrand O., Nödler K., Licha T., Sauter M., Geyer T. Identification of the attenuation potential of a karst aquifer by an artificial dualtracer experiment with caffeine. Water. Res. 2012, 46(16):5381-5388.
19. Hillebrand O., Musallam S., Scherer L., Nödler K., Licha T. The challenge of sample-stabilisation in the era of multi-residue analytical methods: a practical guideline for the stabilisation of 46 organic micropollutants in aqueous samples. Sci. Total. Environ. 2013, 454-455:289-298.
20. Huerta-Fontela M., Galceran M.T., Ventura F. Occurrence and removal of pharmaceuticals and hormones through drinking water treatment. Water. Res. 2011, 45(3):1432-1442.
21. Huntscha S., Singer H.P., McArdell C.S., Frank C.E., Hollender J. Multiresidue analysis of 88 polar organic micropollutants in ground, surface and wastewater using online mixed-bed multilayer solid-phase extraction coupled to high performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. A. 2012, 1268:74-83.
22. Kahle M., Buerge I.J., Müller M.D., Poiger T. Hydrophilicanthropogenic markers for quantification of wastewater contamination inground- and surface waters. Environ. Toxicol. Chem. 2009, 28:2528-2536.
23. Kasprzyk-Hordern B., Dinsdale R.M., Guwy A.J. The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK. Water. Res. 2008, 42(13):3498-3518.
24. Kern S., Baumgartner R., Helbling D.E., Hollender J., Singer H., Loos M.J., Schwarzenbach R.P., Fenner K. A tiered procedure for assessing the formation of biotransformation products of pharmaceuticals and biocides during activated sludge treatment. J. Environ. Monit. 2010, 12(11):2100-2111.
25. Klosterhaus S.L., Grace R., Hamilton M.C., Yee D. Method validation and reconnaissance of pharmaceuticals, personal care products, and alkylphenols in surface waters, sediments, and mussels in an urban estuary. Environ. Int. 2013, 54:92-99.
26. Kunkel U., Radke M. Fate of pharmaceuticals in rivers: deriving a benchmark dataset at favorable attenuation conditions. Water. Res. 2012, 46(17):5551-5565.
27. Lange F.T., Scheurer M., Brauch H.-J. Artificial sweeteners - a recently recognized class of emerging environmental contaminants: a review. Anal. Bioanal. Chem. 2012, 403(9):2503-2518.
28. Maeng S.K., Sharma S.K., Lekkerkerker-Teunissen K., Amy G.L. Occurrence and fate of bulk organic matter and pharmaceutically active compounds in managed aquifer recharge: a review. Water. Res. 2011, 45(10):3015-3033.
29. Majewsky M., Gallé T., Bayerle M., Goel R., Fischer K., Vanrolleghem P.A. Xenobiotic removal efficiencies in wastewater treatment plants: residence time distributions as a guiding principle for sampling strategies. Water. Res. 2011, 45(18):6152-6162.
30. Margot J., Kienle C., Magnet A., Weil M., Rossi L., de Alencastro L.F., Abegglen C., Thonney D., Chèvre N., Schärer M., Barry D.A. Treatment of micropollutants in municipal wastewater: ozone or powdered activated carbon?. Sci. Total. Environ. 2013, 461-462:480-498.
31. Nödler K., Licha T., Bester K., Sauter M. Development of a multi-residue analytical method, based on liquid chromatography-tandem mass spectrometry, for the simultaneous determination of 46 micro-contaminants in aqueous samples. J. Chromatogr. A. 2010, 1217(42):6511-6521.
32. Nödler K., Licha T., Fischer S., Wagner B., Sauter M. A case study on the correlation of micro-contaminants and potassium in the Leine River (Germany). Appl. Geochem. 2011, 26(12):2172-2180.
33. Nödler K., Licha T., Barbieri M., Pérez S. Evidence for the microbially mediated abiotic formation of reversible and non-reversible sulfamethoxazole transformation products during denitrification. Water. Res. 2012, 46(7):2131-2139.
34. Oosterhuis M., Sacher F., ter Laak T.L. Prediction of concentration levels of metformin and other high consumption pharmaceuticals in wastewater and regional surface water based on sales data. Sci. Total. Environ. 2013, 442:380-388.
35. Ort C., Lawrence M.G., Rieckermann J., Joss A. Sampling for pharmaceuticals and personal care products (PPCPs) and illicit drugs in wastewater systems: are your conclusions valid? A critical review. Environ. Sci. Technol. 2010, 44(16):6024-6035.
36. Reh R., Licha T., Geyer T., Nödler K., Sauter M. Occurrence and spatial distribution of organic micro-pollutants in a complex hydrogeological karst system during low flow and high flow periods, results of a two-year study. Sci. Total. Environ. 2013, 443:438-445.
37. Schaffer M., Boxberger N., Börnick H., Licha T., Worch E. Sorption influenced transport of ionizable pharmaceuticals onto a natural sandy aquifer sediment at different pH. Chemosphere 2012, 87(5):513-520.
38. Scheurer M., Brauch H.-J., Lange F.T. Analysis and occurrence of seven artificial sweeteners in German waste water and surface water and in soil aquifer treatment (SAT). Anal. Bioanal. Chem. 2009, 394(6):1585-1594.
39. Scheurer M., Ramil M., Metcalfe C.D., Groh S., Ternes T.A. The challenge of analyzing beta-blocker drugs in sludge and wastewater. Anal. Bioanal. Chem. 2010, 396(2):845-856.
40. Scheurer M., Storck F.R., Brauch H.-J., Lange F.T. Performance of conventional multi-barrier drinking water treatment plants for the removal of four artificial sweeteners. Water. Res. 2010, 44(12):3573-3584.
41. Scheurer M., Storck F.R., Graf C., Brauch H.-J., Ruck W., Lev O., Lange F.T. Correlation of six anthropogenic markers in wastewater, surface water, bank filtrate, and soil aquifer treatment. J. Environ. Monit. 2011, 13(4):966-973.
42. Sontheimer H., Heilker E., Jekel M., Nolte H., Vollmer H. The Muelheim process. J. AWWA 1978, 70(7):393-396.
43. Stadler L.B., Ernstoff A.S., Aga D.S., Love N.G. Micropollutant fate in wastewater treatment: redefining "removal". Environ. Sci. Technol. 2012, 46(19):10485-10486.
44. Takayama F., Saito K., Yoshinaga T., Morita M., Hata S., Esumi Y., Jin Y., Okamura Y. Metabolic fate of losartan, a new angiotensin II receptor antagonist. (1): absorption, distribution, metabolism and excretion after single administration in rats. Drug Metab. Pharmacokinet. 1995, 10(2):223-243.
45. Ternes T.A., Meisenheimer M., McDowell D., Sacher F., Brauch H.-J., Haist-Gulde B., Preuss G., Wilme U., Zulei-Seibert N. Removal of pharmaceuticals during drinking water treatment. Environ. Sci. Technol. 2002, 36(17):3855-3863.
46. Unceta N., Sampedro M.C., Abu Bakar N.K., Gómez-Caballero A., Goicolea M.A., Barrio R.J. Multi-residue analysis of pharmaceutical compounds in wastewaters by dual solid-phase microextraction coupled to liquid chromatography electrospray ionization ion trap mass spectrometry. J. Chromatogr. A. 2010, 1217(20):3392-3399.
47. WHO World Health Statistics, A Snapshot of Global Health 2012, WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva, Switzerland.
48. Wolf L., Zwiener C., Zemann M. Tracking artificial sweeteners and pharmaceuticals introduced into urban groundwater by leaking sewer networks. Sci. Total. Environ. 2012, 430:8-19.